|Bid||0.0000 x 2900|
|Ask||0.0000 x 4000|
|Day's Range||0.2100 - 0.2265|
|52 Week Range||0.2100 - 2.4700|
|Beta (5Y Monthly)||-0.10|
|PE Ratio (TTM)||4.27|
|Earnings Date||Jan 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier in China, today announced the Company's subsidiary Zhejiang Farmmi Biotechnology Co., Ltd., is continuing its growth with another new product order for its popular dried whole Shiitake mushrooms. The customer will export Farmmi's Shiitake mushrooms to Southwest Asia.
NEW YORK, NY / ACCESSWIRE / September 15, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $81 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares for Farmmi, Inc.
Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier in China, today announced that it has completed an underwritten public offering of ordinary shares and pre-funded warrants to purchase ordinary shares ("Offering"), with gross proceeds to the Company expected to be approximately $81 million, before deducting underwriting discounts and commissions and other estimated expenses payable by the Company. The Offering included 368,261,717 of the Company's ordinary